Author

Elisa Oltra

School of Medicine and Health Sciences, Catholic University of Valencia, Valencia, SpainORCID 0000-0003-0598-2907Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Esther Masia· 1 shared Eva Martín‐MartíneziD· 1 shared Karen Giménez-OrengaiD· 1 shared Lubov NathansoniD· 1 shared Maria Jesus VicentiD· 1 shared Maria LjungstromiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

6 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Esther Masia

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintNov 13, 2026

AlphaScreen profiling of extracellular vesicle-associated platelet, immune, and vascular markers reveals disease-specific signatures in ME/CFS, fibromyalgia, and long COVID

Maria Ljungstrom, Esther Masia, Maria Jesus Vicent, Elisa Oltra

This study uses AlphaScreen profiling of extracellular vesicle markers to identify disease-specific signatures in ME/CFS, fibromyalgia, and long COVID, revealing distinct patterns of platelet, immune, and vascular pathway dysregulation.

DOI 10.64898/2026.11.10.765688

humanproteomics

𝕏 PostBluesky

ImmunologyeLifePeer-reviewedFeb 5, 2025

HERV activation segregates ME/CFS from fibromyalgia while defining a novel nosologic entity

Karen Giménez-Orenga, Eva Martín‐Martínez, Lubov Nathanson, Elisa Oltra

This study uses HERV-V3 microarrays to analyze blood samples from ME/CFS, FM, co-diagnosed, and healthy patients, revealing distinct HERV expression profiles that differentiate these conditions.

14 citationstop 5%

humanbulk RNA-seq

𝕏 PostBluesky